Graeme Robb

15PUBLICATIONS
49CO-AUTHORS
Gene and molecular therapyBioinformatic methods developmentMolecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 22, 2026
Use of Human Dose Prediction Metrics to Enable Discovery of AZD3470, an MTA-Cooperative PRMT5 Inhibitor in Clinical Evaluation.

|Sep 10, 2024
Automated Adaptive Absolute Binding Free Energy Calculations.

Finlay Clark, Graeme R Robb, Daniel J Cole

|Aug 12, 2024
Accelerated Discovery of Carbamate Cbl-b Inhibitors Using Generative AI Models and Structure-Based Drug Design.

Taylor R Quinn, Kathryn A Giblin, Clare Thomson

|Jul 31, 2024
Discovery and <i>In Vivo</i> Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity.

James M Smith, Bernard Barlaam, David Beattie

|Mar 11, 2024
Development of a Series of Pyrrolopyridone MAT2A Inhibitors.

Stephen J Atkinson, Sharan K Bagal, Argyrides Argyrou

|Feb 02, 2024
Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood-Brain Barrier: The Discovery of AZD1390.

Kurt G Pike, Thomas A Hunt, Bernard Barlaam

Pageof 3

Frequent Collaborators

4 joint publications

Michelle L Lamb

4 joint publications

James Smith

4 joint publications

Elisabetta Chiarparin

4 joint publications

Marianne Schimpl